enocitabine has been researched along with Leukemia in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 26 (92.86) | 18.7374 |
| 1990's | 1 (3.57) | 18.2507 |
| 2000's | 1 (3.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asou, N; Horikawa, K; Koh, Y; Matsuno, F; Mitsuya, H; Nakamura, M; Tajiri, T; Tatetsu, H; Yonemura, Y | 1 |
| Nakamura, T; Ueda, T | 1 |
| Yamada, K | 2 |
| Amaki, K | 1 |
| Hattori, M; Hayashi, Y; Honda, T; Sampi, K | 1 |
| Tsukagoshi, S | 1 |
| Kato, Y; Kawashima, K; Morishima, Y; Ohno, R; Tanimoto, M; Yamada, K | 1 |
| Akiyama, Y; Ando, S; Johno, I; Kagawa, D; Nakamura, T; Sasada, M; Uchino, H; Ueda, T | 1 |
| Hirano, M; Ino, T; Matsui, T; Morishita, Y; Nakamura, K; Ono, Y; Saito, M; Shigemura, H; Shimizu, S | 1 |
| Ohno, R; Yamada, K | 1 |
| Kimura, K | 1 |
| Amaki, I; Hattori, K; Hirota, Y; Hoshino, A; Ichimaru, M; Ito, M; Kimura, I; Kimura, K; Maekawa, T; Masaoka, T; Nakamura, T; Ogawa, M; Oguro, M; Ohta, K; Osamura, S; Sakai, Y; Shimoyama, M; Takaku, F; Uzuka, Y; Yamada, K | 1 |
| Oguro, M; Sueyama, H; Takagi, T | 1 |
| Kato, Y; Suzuki, H; Yamada, K | 1 |
| Matsuura, Y; Oguro, M; Sakai, C; Takagi, T | 1 |
| Ishikawa, I; Kaneko, H; Katoh, M; Kojima, N; Shirai, T; Umeda, M; Yamaguchi, R; Yamauchi, M | 1 |
| Egami, K; Itoh, K; Kobayashi, K; Matsuda, T; Nakamura, S; Nakanishi, J; Natori, H; Ohtake, S; Tanaka, K; Yoshida, T | 1 |
| Esumi, N; Fujiwara, F; Hashida, T; Ikushima, S; Imashuku, S; Ishii, T; Morioka, Y; Okano, S; Todo, S; Yoshihara, T | 1 |
| Kakita, T; Kubo, A; Moriguchi, T; Nakamura, T; Nishimura, T; Sasada, M; Uchino, H; Ueda, T | 1 |
| Hiyoshi, M; Kawarabayashi, K; Kishida, T; Kojima, K; Sagawa, H; Sannomiya, Y; Sasaki, A; Yamane, T; Yokomatsu, Y; Yoshikawa, T | 1 |
| Hattori, M; Kaneko, Y; Sakurai, M; Sampi, K | 1 |
| Horiuchi, A; Kanamaru, A; Kawagoe, H; Kitani, T; Masaoka, T; Nagai, K; Shibata, H; Yasunaga, K; Yonezawa, T | 1 |
| Hirano, M; Ikeda, Y; Kimura, K; Kobayashi, M; Ohara, K; Ohno, R; Ohta, K; Yamada, K; Yoshikawa, H; Yoshikawa, S | 1 |
| Hirai, J; Ito, K; Kanno, M; Kobayashi, K; Matsuda, T; Nakamura, S; Ohtake, S; Tachimori, K; Yoshida, T | 1 |
| Amaki, I; Hattori, K; Hirota, Y; Hoshino, A; Ichimaru, M; Ito, M; Kimura, I; Kimura, K; Maekawa, T; Ohno, R | 1 |
| Nakamura, T; Uchida, M; Ueda, T | 1 |
| Morishima, Y; Naoe, T; Ohno, R; Yamada, K; Yokomaku, S | 1 |
3 review(s) available for enocitabine and Leukemia
| Article | Year |
|---|---|
[Chemotherapy of the malignancies from the viewpoint of pharmacology and biochemistry of cytosine arabinoside (ara-C) and its derivatives].
Topics: Ancitabine; Cytarabine; Humans; Kinetics; Leukemia | 1982 |
[Symposium on treatment of cancer. 1. Chemotherapy of acute leukemia in adults].
Topics: Aclarubicin; Acute Disease; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Clinical Trials as Topic; Cytarabine; Doxorubicin; Humans; Interferon Type I; Leukemia; Middle Aged; Naphthacenes | 1984 |
Overview of progress in hematology in 1981 with special reference to leukocyte.
Topics: Aclarubicin; Acute Disease; Adult; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Cells, Cultured; Child; Cytarabine; Deoxycytidine Monophosphate; Drug Therapy, Combination; Humans; Kinetics; Leukemia; Leukemia L1210; Leukocytes; Naphthacenes | 1982 |
5 trial(s) available for enocitabine and Leukemia
| Article | Year |
|---|---|
[Symposium on treatment of cancer. 1. Chemotherapy of acute leukemia in adults].
Topics: Aclarubicin; Acute Disease; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Clinical Trials as Topic; Cytarabine; Doxorubicin; Humans; Interferon Type I; Leukemia; Middle Aged; Naphthacenes | 1984 |
[Development of new antileukemic agents].
Topics: Aclarubicin; Adolescent; Adult; Aged; Animals; Antibiotics, Antineoplastic; Clinical Trials as Topic; Cytarabine; Humans; Leukemia; Mice; Middle Aged; Naphthacenes | 1981 |
[Urotoxicity of enocitabine (BH-AC) and aclarubicin (ACM) in pediatric patients with hematological malignancies].
Topics: Aclarubicin; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Female; Hematuria; Humans; Infant; Leukemia; Lymphoma; Male; Multicenter Studies as Topic; Retrospective Studies | 1988 |
[A phase III study of BHAC-MMP (behenoyl-ara-C, mitoxantrone, 6-mercaptopurine prednisolone) in acute leukemia. Hanshin Cooperative Study Group of Hematological Disorders].
Topics: Acute Disease; Adolescent; Adult; Aged; Anthraquinones; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cytarabine; Female; Humans; Leukemia; Leukemia, Lymphoid; Male; Mercaptopurine; Middle Aged; Mitoxantrone; Prednisolone | 1986 |
[Mitoxantrone as combination chemotherapy in patients with acute leukemia. Tokai Blood Cancer Study Group].
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials as Topic; Cytarabine; Female; Humans; Leukemia; Male; Mercaptopurine; Middle Aged; Mitoxantrone; Prednisolone; Vincristine | 1986 |
21 other study(ies) available for enocitabine and Leukemia
| Article | Year |
|---|---|
[Allergic reaction against an emulsifier, HCO-60, contained in multamin and enocitabine].
Topics: Acute Disease; Antineoplastic Agents; Castor Oil; Cytarabine; Drug Hypersensitivity; Female; Humans; Leukemia; Middle Aged; Surface-Active Agents; Urticaria; Vitamins | 2003 |
[Treatment of acute leukemia].
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Deoxycytidine Monophosphate; Humans; Leukemia; Mercaptopurine; Prednisolone | 1984 |
[Aclacinomycin A and behenoyl ara-C combination chemotherapy for untreated acute non-lymphocytic leukemia].
Topics: Aclarubicin; Acute Disease; Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cytarabine; Female; Humans; Leukemia; Male; Middle Aged; Naphthacenes | 1983 |
[Sunrabin for injection].
Topics: Acute Disease; Adult; Animals; Antineoplastic Agents; Cytarabine; Humans; Injections; Lethal Dose 50; Leukemia; Mice; Rats | 1983 |
Pharmacologic and clinical studies of N4-behenoyl-1-beta-D-arabinofuranosylcytosine.
Topics: Animals; Bone Marrow; Cytarabine; Drug Evaluation; Female; Haplorhini; Humans; Leukemia; Macaca; Male; Middle Aged; Neoplasms; Remission, Spontaneous | 1980 |
Pharmacokinetics of N4-behenoyl-1-beta-D-arabinofuranosylcytosine in patients with acute leukemia.
Topics: Acute Disease; Adult; Antineoplastic Agents; Arabinofuranosyluracil; Bone Marrow; Child; Child, Preschool; Chromatography, High Pressure Liquid; Cytarabine; Erythrocytes; Gas Chromatography-Mass Spectrometry; Humans; Infant; Infusions, Parenteral; Kinetics; Leukemia; Middle Aged; Time Factors | 1983 |
[Treatment of acute non-lymphocytic leukemia with concurrent administration of N4-behenoyl-beta-D-arabinofuranosylcytosine, aclacinomycin A, 6-mercaptopurine and prednisolone; a pilot study (author's transl)].
Topics: Aclarubicin; Adult; Cytarabine; Drug Therapy, Combination; Female; Humans; Leukemia; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Male; Mercaptopurine; Middle Aged; Naphthacenes; Prednisolone | 1981 |
Phase I--II study of N4-behenoyl-1-beta-D-arabinofuranosylcytosine.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Cytarabine; Drug Evaluation; Female; Humans; Leukemia; Male; Middle Aged; Neoplasms | 1981 |
[Treatment of acute leukemia with newly synthesized N4-behenoyl-l-beta-D-arabinofuranosylcytosine (BH-AC) (author's transl)].
Topics: Acute Disease; Adolescent; Adult; Aged; Cytarabine; Drug Evaluation; Female; Humans; Leukemia; Male; Middle Aged | 1981 |
Phase III study of N4-behenoyl-l-beta-D-arabinofuranosylcytosine in adult acute leukemia-BH-AC-DMP therapy.
Topics: Acute Disease; Adolescent; Adult; Cytarabine; Daunorubicin; Female; Humans; Leukemia; Male; Middle Aged; Prednisolone; Thioinosine | 1980 |
[In vitro effect of combined use of BH-AC and nitrosourea derivatives against adriamycin-resistant human leukemia cell line].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Leukemia; Nimustine; Nitrosourea Compounds; Tumor Cells, Cultured | 1991 |
[The effect of antileukemic drugs on superoxide (O2-) production by human neutrophils].
Topics: Aclarubicin; Antineoplastic Agents; Cytarabine; Dose-Response Relationship, Drug; Humans; Leukemia; Naphthacenes; Neutrophils; Superoxides | 1987 |
[New combination chemotherapy of adult acute nonlymphocytic leukemia].
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Leukemia; Male; Methotrexate; Middle Aged; Prednisolone; Vincristine; Zinostatin | 1985 |
[The effect of N4-behenoyl-1-beta-D-arabinofuranosylcytosine on human erythrocytes].
Topics: Acute Disease; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood Sedimentation; Cytarabine; Erythrocytes; Humans; Leukemia; Osmotic Fragility | 1987 |
["B-triple V" therapy as a initial induction treatment of acute leukemias].
Topics: Acute Disease; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Humans; Leukemia; Male; Middle Aged; Remission Induction; Vinblastine; Vincristine | 1987 |
Aclacinomycin A and behenoyl arabinofuranosylcytosine combination chemotherapy for previously untreated acute leukemia.
Topics: Aclarubicin; Actuarial Analysis; Acute Disease; Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Child; Child, Preschool; Cytarabine; Humans; Leukemia; Middle Aged; Naphthacenes | 1986 |
[Clinical and pharmacokinetic studies of high dose N4-behenoyl-1-beta-D-arabinofuranosylcytosine].
Topics: Antineoplastic Agents; Cytarabine; Humans; Kinetics; Leukemia; Lymphoma, Non-Hodgkin | 1987 |
Phase I clinical and pharmacokinetic study of N4-behenoyl-1-beta-D-arabinofuranosylcytosine.
Topics: Adult; Aged; Antineoplastic Agents; Cytarabine; Dose-Response Relationship, Drug; Drug Evaluation; Drug Tolerance; Female; Hematopoiesis; Humans; Kinetics; Leukemia; Lymphoma; Male; Metabolic Clearance Rate; Middle Aged | 1986 |
[Strategy of chemotherapy of a patient with acute leukemia based on the mechanism of action of drugs].
Topics: Acute Disease; Cytarabine; Erythrocytes; Humans; Kinetics; Leukemia; Mercaptopurine | 1986 |
[Prognostic factors related to remission duration and the effects of maintenance therapy in BHAC-DMP therapy in adult acute non-lymphocytic leukemia patients].
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Deoxycytidine Monophosphate; Humans; Leukemia; Middle Aged; Prognosis; Regression Analysis; Remission Induction | 1986 |
Chemotherapy of acute leukemia in adults.
Topics: Aclarubicin; Acute Disease; Adult; Antineoplastic Agents; Cytarabine; Doxorubicin; Drug Evaluation; Humans; Interferon Type I; Leukemia; Naphthacenes | 1985 |